<DOC>
	<DOC>NCT01360502</DOC>
	<brief_summary>This is a prospective study designed to assess safety and potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.</brief_summary>
	<brief_title>Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices</brief_title>
	<detailed_description>MiroCam (IntroMedic, Ltd, Seoul, Korea) is a small bowel capsule endoscope using human body communication for data transmission. There is a concern of potential interactions between cardiac devices and capsule endoscope. This clinical study was designed to evaluate the potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<criteria>1. age 20 years or older 2. cardiac pacemaker or implantable cardiac defibrillator 3. gastrointestinal disease 1. previous GI perforation or obstruction history 2. known or suspected GI stricture 3. marked GI dysmotility 4. uncompensated heart failure (EF ≤30% or Killip's classification class ≥ III) 5. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>capsule endoscopy</keyword>
	<keyword>cardiac pacemaker</keyword>
	<keyword>implantable cardiac defibrillator</keyword>
</DOC>